In the Journals

This feature offers timely executive summaries of the most relevant journals in rheumatology. Through peer “Perspectives,” full bibliographical information and links to the original journal abstract, In the Journals are a step wider and deeper than journal reviews health care professionals may be accustomed.

In the Journals

In patients with RA who fail one TNFi, risk of serious infection is similar between rituximab, second TNFi treatment

September 18, 2017
In the Journals

Study explores malignant neoplasm risk among patients with RA treated with bDMARDs

September 18, 2017
There was no substantial difference in the overall risk of cancer among patients with rheumatoid arthritis treated with tumor necrosis factor…
In the Journals

Physical activity did not change 6 months after total hip or knee arthroplasty

September 15, 2017
There was no significant change in physical activity 6 months after total knee or hip joint replacement surgery, despite improvements in quality of…
In the Journals

Burden of arthritis expected to increase among Australians

September 15, 2017
A population-level study for Australia, projected an increased prevalence of osteoarthritis and rheumatoid arthritis and health care costs related to…
In the Journals

Tapering TNFi dose by 33% did not affect RA flares

September 15, 2017
In patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors, dose tapering by 33% did not appear to diminish clinical…
In the Journals

Study: SLE affects more black women than other racial, ethnic groups in San Francisco County

September 14, 2017
Black, Asian and Hispanic women living in San Francisco County had an increased burden of systemic lupus erythematosus, according to the California…
In the Journals

Study: Nonadherence to SLE, RA treatments is a persistent and common issue

September 14, 2017
In the treatment of systemic lupus erythematosus and rheumatoid arthritis, treatment nonadherence is an ongoing and common problem with potential…
In the Journals

Rheumatoid factor positivity, not anti-CCP positivity, linked with CV risk

September 13, 2017
Rheumatoid factor positivity, rather than anticyclic citrullinated peptide antibody positivity, appears to be associated with 10-year risk of…
In the Journals

Romosozumab followed by alendronate lowered risk for fracture in women with osteoporosis

September 12, 2017
There was a significantly lower risk for fracture seen among postmenopausal women with osteoporosis who received romosozumab followed by alendronate…
In the Journals

Anterior uveitis impacted physical QoL, particularly with underlying SpA

September 12, 2017
Advertisement
Advertisement